Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
42.15 EUR | -0.47% | +4.72% | +3.31% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.62 | 4.81 | 8.76 | 9.55 | 10.58 | |||||
Return on Total Capital | 9.49 | 5.86 | 10.66 | 12.14 | 13.47 | |||||
Return On Equity % | 11.22 | 6.47 | 13.82 | 17.61 | 19.33 | |||||
Return on Common Equity | 11.16 | 6.43 | 13.75 | 17.55 | 19.25 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 64.49 | 62.24 | 65.52 | 67.21 | 66.1 | |||||
SG&A Margin | 48.62 | 48.63 | 46.87 | 47.12 | 45.5 | |||||
EBITDA Margin % | 16.08 | 14.07 | 18.61 | 21.78 | 22.98 | |||||
EBITA Margin % | 15.62 | 13.49 | 18.18 | 19.78 | 20.91 | |||||
EBIT Margin % | 15.09 | 12.77 | 17.99 | 19.57 | 20.73 | |||||
Income From Continuing Operations Margin % | 10.55 | 8.44 | 12.78 | 14.18 | 14.99 | |||||
Net Income Margin % | 10.46 | 8.36 | 12.68 | 14.08 | 14.87 | |||||
Net Avail. For Common Margin % | 10.46 | 8.36 | 12.68 | 14.08 | 14.87 | |||||
Normalized Net Income Margin | 9.35 | 7.78 | 11.41 | 12.27 | 12.69 | |||||
Levered Free Cash Flow Margin | 7.59 | 8.83 | -12.76 | 4.54 | 5.28 | |||||
Unlevered Free Cash Flow Margin | 7.75 | 8.98 | -12.51 | 4.25 | 5.85 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.81 | 0.6 | 0.78 | 0.78 | 0.82 | |||||
Fixed Assets Turnover | 39.35 | 18.48 | 6.82 | 4.66 | 4.94 | |||||
Receivables Turnover (Average Receivables) | 5.22 | 4.09 | 5.31 | 5.35 | 5.74 | |||||
Inventory Turnover (Average Inventory) | 1.66 | 1.39 | 1.99 | 1.81 | 1.52 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.55 | 4.09 | 3.19 | 2.26 | 2.7 | |||||
Quick Ratio | 2.61 | 2.61 | 1.96 | 1.29 | 1.47 | |||||
Operating Cash Flow to Current Liabilities | 0.43 | 0.45 | 0.49 | 0.32 | 0.43 | |||||
Days Sales Outstanding (Average Receivables) | 69.91 | 89.5 | 68.79 | 68.27 | 63.62 | |||||
Days Outstanding Inventory (Average Inventory) | 219.88 | 262.48 | 183.73 | 201.34 | 239.94 | |||||
Average Days Payable Outstanding | 141.38 | 168.56 | 128.96 | 132.44 | 127.86 | |||||
Cash Conversion Cycle (Average Days) | 148.41 | 183.42 | 123.56 | 137.17 | 175.71 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 4.66 | 4.05 | 23.09 | 26.9 | 21.46 | |||||
Total Debt / Total Capital | 4.45 | 3.89 | 18.76 | 21.2 | 17.67 | |||||
LT Debt/Equity | 1.79 | 1.24 | 20.11 | 22.37 | 17.21 | |||||
Long-Term Debt / Total Capital | 1.71 | 1.19 | 16.34 | 17.63 | 14.17 | |||||
Total Liabilities / Total Assets | 22.72 | 19.89 | 33.9 | 39.81 | 33.52 | |||||
EBIT / Interest Expense | 60.94 | 52.06 | 44.6 | -42.38 | 22.41 | |||||
EBITDA / Interest Expense | 68.43 | 61.22 | 49.14 | -48.2 | 25.22 | |||||
(EBITDA - Capex) / Interest Expense | 65.8 | 51.74 | -2.48 | -40.11 | 24.2 | |||||
Total Debt / EBITDA | 0.26 | 0.36 | 1.13 | 1.02 | 0.74 | |||||
Net Debt / EBITDA | -2.24 | -2.8 | -0.48 | 0.03 | -0.04 | |||||
Total Debt / (EBITDA - Capex) | 0.27 | 0.43 | -22.34 | 1.22 | 0.77 | |||||
Net Debt / (EBITDA - Capex) | -2.33 | -3.31 | 9.42 | 0.04 | -0.05 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 6.35 | -24.14 | 52.66 | 26 | 13 | |||||
Gross Profit, 1 Yr. Growth % | 5.24 | -26.79 | 60.73 | 29.24 | 11.14 | |||||
EBITDA, 1 Yr. Growth % | 2.91 | -41.49 | 58.61 | 36.95 | 10.88 | |||||
EBITA, 1 Yr. Growth % | 14.3 | -32.17 | 117.41 | 38.54 | 20.73 | |||||
EBIT, 1 Yr. Growth % | 10.4 | -35.8 | 115.05 | 37.11 | 19.7 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 7.21 | -39.29 | 131.09 | 39.76 | 19.46 | |||||
Net Income, 1 Yr. Growth % | 7.39 | -39.36 | 131.55 | 39.99 | 19.31 | |||||
Normalized Net Income, 1 Yr. Growth % | 8.51 | -36.84 | 123.91 | 35.42 | 16.9 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 8.16 | -36.67 | 126.98 | 47.41 | 14.13 | |||||
Accounts Receivable, 1 Yr. Growth % |